Sinus Forte 60 Tablets

$63.95

 

Sinus Forte contains herbs traditionally used in Western herbal medicine; Eyebright to relieve symptoms of allergic rhinitis, symptoms of sinusitis and sneezing, and Echinacea purpurea root to support immune system health and relieve symptoms of mild upper respiratory tract infections.

Description

  • Eyebright is traditionally used in Western herbal medicine to:
    – reduce mild upper respiratory tract congestion, support healthy mucous membranes and relieve inflammation
    – relieve symptoms of allergic rhinitis, symptoms of sinusitis and hay fever such as sneezing
  • Echinacea purpurea root has been traditionally used in Western herbal medicine to support immune system health and relieve symptoms of mild upper respiratory tract infections
  • Golden Rod is traditionally used in Western herbal medicine to reduce excess mucous and  promote sweating and perspiration

Additional information

Ingredients:

Each tablet contains:
Euphrasia officinalis (Eyebright) extract 1.3 mL
derived from herb dry 650 mg
Solidago virgaurea (Golden Rod) extract 1.3 mL
derived from herb dry 650 mg
Echinacea purpurea (Echinacea) extract 740 microlitre
derived from root dry 370 mg
Hydrastis canadensis (Golden Seal) extract 375 microlitre
derived from root & rhizome dry 125 mg
Capsicum annuum (Cayenne) extract 30 microlitre
derived from fruit dry 10 mg

Directions for use:

Adults: 1 tablet 3-4 times daily.

Warnings, Cautions and Contraindications:

Not to be used in children under two years of age without medical advice
Use with caution during pregnancy
The risk of allergic reaction to Echinacea is very small, especially if preparations of the root are used since these are free of pollens
Echinacea is contraindicated for long-term use in patients taking immunosuppressant medication (eg transplant patients) – short-term therapy only is suggested in this instance
Caution is advised in patients receiving midazolam by injection
Caution in those taking theophylline as Cayenne may increase its absorption and bioavailability
Discontinue 7 days prior to general anaesthesia
If patient symptoms persist, seek additional professional advice